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Rising pertussis incidence has prompted a number of countries to implement maternally targeted vaccination strategies to protect vulnerable infants, but questions remain about the optimal design of such strategies. We simulated pertussis transmission within an individual-based model parameterized to match Australian conditions, explicitly linking infants and their mothers to estimate the effectiveness of alternative maternally targeted vaccination strategies (antenatal delivery vs. postnatal delivery) and the benefit of revaccination over the course of multiple pregnancies. For firstborn infants aged less than 2 months, antenatal immunization reduced annual pertussis incidence by 60%, from 780 per 100,000 firstborn children under age 2 months (interquartile range (IQR), 682-862) to 315 per 100,000 (IQR, 260-370), while postnatal vaccination produced a minimal reduction, with an incidence of 728 per 100,000 (IQR, 628-789). Subsequent infants obtained limited protection from a single antenatal dose, but revaccinating mothers during every pregnancy decreased incidence for these infants by 58%, from 1,878 per 100,000 subsequent children under age 2 months (IQR, 1,712-2,076) to 791 per 100,000 (IQR, 683-915). Subsequent infants also benefited from household-level herd immunity when antenatal vaccination for every pregnancy was combined with a toddler booster dose at age 18 months; incidence was reduced to 626 per 100,000 (IQR, 548-691). Our approach provides useful information to aid consideration of alternative maternally targeted vaccination strategies and can inform development of outcome measures for program evaluation. computer simulation; disease transmission; immunity; infectiousness; maternally acquired immunity; pertussis vaccine; population dynamics; whooping cough Abbreviations: IQR, interquartile range; IRR, incidence rate ratio; NIP, national immunization program; POLYMOD, Improving Public Health Policy in Europe through the Modeling and Economic Evaluation of Interventions for the Control of Infectious Diseases.
Control of pertussis remains problematic, despite the implementation of high-coverage mass vaccination in many countries more than 60 years ago. Improved ability to identify mild cases has contributed to rising pertussis incidence since the 1990s in some populations (1) . However, increased numbers of infant deaths in the United States and the United Kingdom in recent epidemics have provided evidence of genuine resurgence (2, 3) . Maternally targeted vaccination strategies, in which vaccine is delivered either antenatally or postnatally (so-called "cocoon" immunization), have been implemented in the United States (2), the United Kingdom (3), and Australia (4) as emergency measures in an effort to regain control of pertussis. Questions remain about the sustainability and cost-effectiveness of household-targeted strategies in the long term, the relative benefits of antenatal vaccination versus "cocooning," and the optimal application of maternal immunization approaches for protection over the course of multiple pregnancies.
Households are an important identified source of infection for infants; but with no identified infector in approximately half of infant cases (5), how effective will strategies focused on reducing the risk of infection in the household be?
Vaccinating mothers only during the postpartum period has been found to provide a modest reduction in risk of pertussis transmission to the infant (6) . When this "cocoon" strategy was extended to include vaccination of both parents, infant risk of pertussis was more than halved (4) . The effectiveness of antenatal vaccination against laboratory-confirmed pertussis among infants in the United Kingdom is much higher, at approximately 90%, reflecting the fact that this strategy also provides direct protection to the infant through placental transfer of maternal antibodies during the third trimester (3, 7) . While rapid waning of antibodies in the mother may limit the potential for transfer of sufficient levels of antibodies for protection beyond a single pregnancy (8) , the relative benefits of repeated vaccination in subsequent pregnancies and the optimal vaccination interval have not yet been quantified.
We simulated pertussis transmission and maternally targeted vaccination strategies within an individual-based model framework that characterizes individuals by their sex, age, and household. We compared infant infections in households in which the mother was immunized with those in households where the mother was not to separately estimate the overall effectiveness of alternative antenatal and cocoon vaccination strategies at the household level and their population impact on transmission. Our results can inform optimal implementation approaches and provide inputs necessary for cost-effectiveness analyses.
METHODS

Demographic model
We modeled a population using a stochastic individual-based model that tracks the occurrence of 5 life events: birth, death, couple formation, couple dissolution, and leaving home (9) . The model is parameterized using available census and survey data to represent an age distribution, household composition, and vital dynamics consistent with the Australian population across the course of the 20th century (see Web Appendix 1, available at https://academic.oup.com/aje).
In traditional compartmental models, population mixing relevant to infection transmission is configured using matrices that reflect the relative frequency of contact within and between age groups. An important limitation of these compartmental models is that they do not capture the greater intensity of contact that occurs within household settings and cannot explicitly link infants and their mothers. In contrast, household contact patterns arise endogenously in our demographic model as a result of the population structure and dynamics (10) . Community mixing patterns were derived using the mean daily number of contacts reported for the POLYMOD Project (Improving Public Health Policy in Europe through the Modeling and Economic Evaluation of Interventions for the Control of Infectious Diseases), a contact study conducted in Europe (11) . Recent analyses of Australian mixing patterns support the use of POLYMOD data in our model, because qualitative trends such as intergenerational mixing and age assortativity are similar between the two settings, as are the average numbers of encounters per day (12) . Further details on the demographic model are provided in Web Appendix 1, and information on contact parameterization is provided in Web Appendix 2 and Web Table 1 .
Epidemiologic model
Population model of infection and immunity. We applied a pertussis-specific transmission model to the population (Figure 1 ), similar to that used in previous work. In addition to the population's demographic characteristics, we also tracked the current state of infection or immunity of each individual.
People who are naively susceptible to pertussis ( Figure 1 , susceptible naive), having never been infected or vaccinated, become infected (infectious naive) with a probability determined by their Figure 1 . A model of simulated pertussis transmission and maternally targeted vaccination strategies. Infants born to immune mothers (full immunity or partial immunity) start their lives with maternal protection and are fully protected against infection, before waning into the susceptible naive state. Naive individuals are infected at a rate λ(t) and are fully protected upon recovery (full immunity), before waning into a partially immune state from which their immunity can be boosted (partial immunity). If not reexposed, individuals wane to a primed susceptible state (susceptible primed) in which their rate of infection, σλ(t), is reduced in comparison with naive susceptibles (σ = 0.6). If infected from this primed state, individuals are less infectious than those experiencing their first infection (infectious primed). Successfully vaccinated individuals acquire full immunity (full immunity) and thereafter follow the same state transitions as those with immunity acquired following exposure, although with a reduced mean duration of protection. Mean duration in the partial immune state is 74 years following infection and 6 years following vaccination. Other durations in the infectious and immune states are shown, with details provided in Table 1 .
risks of household and community acquisition. These risks depend on an individual's age-specific community mixing patterns and the presence of infected persons in their household and the wider community. Once they have recovered, individuals are fully protected against infection (full immunity).
Over time, an individual's immunity wanes (partial immunity). Persons who are exposed to infection at this stage have their immunity boosted at a rate equivalent to the force of infection, and they regain full protection against infection (full immunity) without contributing to the force of infection. People whose immunity wanes fully without being reexposed and boosted become susceptible once again (susceptible primed), with a reduced susceptibility to infection compared with their first infection. If reinfected (infectious primed), these persons are also less infectious than those experiencing their first infection. Because priming is assumed to permanently modify infection risk and characteristics (13) , the model distinguishes between persons who are naively susceptible and those with immune systems primed by pertussis infection or vaccination.
The model includes parameters to quantify duration and degree of infectiousness, duration and degree of natural, vaccine-, and maternally acquired immunity, rates of community mixing between age groups, and transmission coefficients for the household and community settings. Parameter values for each individual are selected from the distributions described in Table 1 and Web Table 2 . The duration of infectiousness for cases in naive and primed individuals has a mean value of 3 weeks, consistent with published values (14) . The contribution of infections in primed individuals to the force of infection is yet to be convincingly resolved for pertussis (1, 5); we assumed that infections arising in susceptible primed individuals are half as infectious as those in naive individuals.
We assumed that recently exposed or vaccinated individuals have a short duration of full immunity (sampled from an exponential distribution with a mean of 9 months) followed by a much longer duration of partial immunity (15) . We assumed differences in the mean duration of partial immunity following exposure and vaccination of an order of magnitude (74 years and 6 years, respectively), consistent with the findings of previous modeling studies (15, 16) . No differentiation was made between pertussis vaccine formulations in the model-all recent evidence on maternal pertussis immunization relates to the use of acellular pertussis vaccines (3, 7) . Primed susceptibles were considered 0.6 times as likely to be infected as naive susceptibles (15) .
Relationship between maternal immunity and infant immunity. Infants born to mothers who have full or partial immunity ( Figure 1 ) acquire maternal protection. These infants are fully protected against infection until immunity is lost, when they become naively susceptible (susceptible naive). All other infants are naively susceptible from birth.
Passive antibodies acquired by infants from their mothers wane rapidly, with time to depletion likely being dependent on the amount of time elapsed since the mother's last immunizing exposure (17) . Given the uncertainty regarding duration of passive protection, we sampled the duration of maternally acquired immunity from a distribution with a mean of 12 weeks; values of 6 weeks and 24 weeks were explored in a sensitivity analysis.
Application of vaccination in the model. Routine infant vaccination was applied in the model as a primary course at ages 2, 4, and 6 months, followed by a variable number of booster doses, according to the historical and current Australian schedule and coverage (Web Figure 1) . We assumed that infants received either all 3 primary doses or none. Vaccine efficacy was modeled as "all-or-nothing," with successfully vaccinated individuals obtaining full immunity and persons with primary vaccine failure retaining their naive susceptible state. Parameterization of dose response was based on published values (18) and is described in Web Appendix 2.
Calibration. In Australia, there are limited notification data available for model parameterization and calibration, with large gaps due to cessation of national surveillance from 1949 to 1979 (19) . Even where data are available, there is limited comparability over time due to changing ascertainment (20) . We thus applied a qualitative approach to calibration similar to that we used for our previous pertussis modeling work, based on a similar epidemiologic model (15) .
For model calibration, we compared overall incidence patterns from both the prevaccination and vaccination eras to known characteristics of pertussis and key features of (15); and 4) an increase in the proportion of infections occurring in older age groups after the introduction of vaccination (20, 23, 24) . The key objective of calibration was to ensure that the initial conditions of the model matched our understanding of the current state of immunity of the Australian population, guided by our previous pertussis modeling study and serological surveys (15) , to aid prediction of likely vaccine impact. Incidence patterns for an exemplar realization of the model with the chosen transmission parameters (Web Figure 2 ) display a prevaccination epidemic cycle length of approximately 3 years; a more than 10-fold reduction in infections among naive individuals occurring concurrently with an increase in infections among primed individuals; and an upward age shift in the incidence of infection, particularly capturing the rise to prominence of infections in adolescents through the 1990s. Further details of the calibration approach are provided in Web Appendix 2.
Simulation of alternative vaccination strategies
Four alternative vaccination strategies were simulated (100 simulation runs per scenario) to allow estimation of the likely impact of maternally targeted approaches, commencing in model year 2010 and continuing for a period of 10 years:
1. Baseline national immunization program (NIP) schedule (2, 4, and 6 months, 4 years, and 15 years) at historical and current coverage levels (Web Figure 1 ). 2. Baseline NIP + cocoon vaccination (mother only, postpartum; first and every child, coverage 60%). 3. Baseline NIP + antenatal vaccination (first and every child, coverage 80%). 4. Baseline NIP + antenatal vaccination (coverage 80%) + reintroduction of a toddler booster, delivered at 18 months of age (coverage 90%). The 18-month booster was absent from the baseline NIP from 2004 onward but was reintroduced in 2016.
We measured incidence rate ratios (IRR) comparing infants in maternally vaccinated households with infants in nonmaternally vaccinated households.
RESULTS
Role of households in transmission
According to the model, the proportion of neonates passively protected by maternal immunity would have declined rapidly following the introduction of vaccination in 1953 (Figure 2 ). This decline resulted from a reduction in pertussis circulation, reducing opportunities for boosting of adult immunity. In consequence, while most infants (approximately 90%) are likely to have been born with passive protection in the prevaccine era, it is possible that as few as 50% may benefit from passive protection today.
Concordant with observed epidemiology, the model suggested that households were the major source of infection for infants under 1 year of age, with approximately 75% of infections being acquired in the home (Web Appendix 3 and Web Figure 3 ). While the proportion of infant infections occurring in the household setting remained relatively stable over the 20th century, there was a marked shift in the age of the household member attributed as the source of infection (Figure 3) . Since the introduction of vaccination, fewer infant infections have been caused by siblings, with an increasing role for parents as infectors. Distributions (gray areas) are scaled to have equal area to more clearly demonstrate the age shift over a period characterized by a substantial decrease in incidence.
In the predominantly large households associated with the prevaccine era, when disease prevalence was high, the source of infection was almost exclusively other children in the household, with only 12% of household infectors being over age 18 years. After the introduction of vaccination, disease prevalence decreased, and the source of infection was as likely to be a parent as a sibling, with 52% of household infectors being over age 18 years by the late 1990s. Declining birth rates over the course of the 20th century contributed to this shift: Infants were born into households containing few, if any, siblings to pose a risk of infection.
Vaccinating for first pregnancy only
We compared the effect, over a 10-year period, of 4 alternative vaccination strategies (baseline, cocoon, antenatal, and antenatal + 18-month) on infections among infants in their first year of life. We present results for infants under 2 months of age (Figure 4 ), given that this group is the main focus of maternally targeted vaccination; results for infants under 12 months of age are reported in Web Figure 4 and discussed in Web Appendix 3. Results for firstborn ( Figure 4A ) and subsequent ( Figure 4B ) infants were compared, for a scenario in which vaccination was administered only in relation to a woman's first pregnancy occurring in the 10-year period. Figure 4 shows the age distribution of sources of household-acquired infant infection, with the areas of each violin plot scaled proportionally to the incidence of infection in each scenario.
For firstborn children under 2 months of age, the source of household-acquired infection was typically an adult family member. For these infants, the cocoon strategy produced little difference in annual incidence over the 10-year period, with a median incidence of 728 per 100,000 firstborn children under age 2 months (interquartile range (IQR), 628-789) as compared with 780 per 100,000 (IQR, 682-862) under baseline conditions, reflecting ongoing risk to the infant of infection exposure in the community. Marked reductions in incidence were achieved when the mother was immunized antenatally, with median incidence reduced to 315 per 100,000 (IQR, 260-370), improving further with the reintroduction of the 18-month dose (median incidence = 264 per 100,000 (IQR, 235-316)).
Subsequent children had more than twice the infection risk of firstborn children (e.g., baseline incidence for subsequent children under 2 months of age was 1,878 per 100,000 subsequent children under age 2 months (IQR, 1,712-2,076)), due to the fact that their older siblings provided an additional source of household infection exposure. Minimal benefit was conferred on subsequent children by the cocoon strategy administered in relation to a previous pregnancy (median incidence = 1,620 per 100,000 (IQR, 1,510-1,755) ). By comparison, the antenatal strategy reduced median incidence to 1,099 per 100,000 (IQR, 984-1,272), and the antenatal + 18-month strategy substantially reduced the number of infant infections caused by both siblings and parents (median incidence = 885 per 100,000 (IQR, 753-1,002)). By enhancing vaccine protection for both parents and siblings, the antenatal + 18-month strategy was more effective in limiting the introduction of infection into the household, amplifying herd protection of the infant within the household (Web Figure 4) .
Comparison of maternal vaccination delivery options
When vaccine was given only once, antenatal vaccination was clearly more effective at reducing the incidence of infection among infants than cocoon vaccination (Figure 4) . To establish the potential benefits of multiple antenatal vaccinations, we further compared the effectiveness of vaccinating the Figure 4 . Age distribution of sources of household-acquired infant (age <2 months) pertussis infections, when maternal vaccination is delivered for the first birth only. A) Firstborn children; B) subsequent children. Distributions (gray areas) are scaled proportionally to the incidence of infection in each scenario (across 100 simulation runs). The source of household-acquired infection for firstborn infants was typically an adult, with the exception of a small number of blended households containing older children. The antenatal strategies (with or without the 18-month booster) substantially reduced infections, while the cocoon strategy did not provide a discernible reduction. For subsequent children, who were infected by both parents and siblings, maternal vaccination delivered only for the first pregnancy provided only a minimal reduction in incidence. Assumed maternal vaccination coverage was 60% for the cocoon strategy and 80% for the antenatal strategies. Figure 5 . Incidence rate ratios (IRRs) comparing infants born to mothers who received antenatal pertussis vaccination with infants born to mothers who did not, under 3 different antenatal strategies: first birth, every birth, and every birth plus reintroduction of an 18-month booster. Results are shown for firstborn children (left column; parts A, C, and E) and for subsequent children (right column; parts B, D, and F), with rows representing the age groups <2 months (parts A and B), 2-5.99 months (parts C and D), and 6-11.99 months (parts E and F). Boxplots display the median IRR and interquartile ranges over 100 simulation runs for each scenario. Vaccinating for every pregnancy was clearly more effective than vaccinating for the first pregnancy only, especially for the most vulnerable age group (<2 months). The addition of an 18-month dose did not substantially reduce these IRRs, as the benefit of this approach was to reduce the overall level of infection, affecting infants in both maternally vaccinated and non-maternally vaccinated households. Assumed maternal vaccination coverage for the antenatal strategies was 80%.
mother during every pregnancy with the effectiveness of vaccinating the mother during the first pregnancy only. Finally, we compared the additional benefit obtained from reintroduction of the 18-month booster dose. We calculated the pertussis infection IRRs for each simulation run independently, comparing infants born to mothers who received antenatal vaccination with infants born to mothers who did not. We report the distribution of values obtained in the 100 simulation runs for each scenario.
For firstborn children less than 2 months of age, all 3 antenatal strategies (first child, every child, and every child + 18-month booster) provided similar reductions in the risk of pertussis infection ( Figure 5A ). Vaccinating mothers during every pregnancy reduced the risk of pertussis infection among subsequent children under 2 months of age (median IRR = 0.23 (IQR, 0.17-0.33)) visibly more than vaccinating during the first pregnancy only (median IRR = 0.62 (IQR, 0.49-0.83)) ( Figure 5B ). The addition of an 18-month dose did not substantially reduce these IRRs, since the benefit of this approach was a reduction in the overall level of infection, affecting infants in both maternally vaccinated households and non-maternally vaccinated households. Differential effects of the 3 antenatal strategies were less pronounced in children aged 2 months or more ( Figures 5C-5F ). In Web Figure 5 , we extend these results to include the addition of an 18-month dose when vaccination is provided for the first pregnancy only, and in Web Figure 6 , we extend cocoon vaccination to both parents.
In Web Appendix 4, we present the results of a sensitivity analysis on 3 key parameters that define the dynamics of pertussis immunity: time needed to mount an immune response (Web Figure 7) , duration of infant passive protection (Web Figure 8) , and duration of adult protection following vaccination (Web Figure 9 ).
DISCUSSION
Our individual-based model of pertussis transmission showed that maternal vaccination reduces the incidence of pertussis infection in young infants and delivers a clear benefit to households in which mothers are immunized compared with those not so immunized. We found that by providing passive direct protection to infants over a short time period, antenatal vaccination is more effective at reducing pertussis incidence than postnatal "cocoon" approaches. Because maternal immunity is anticipated to wane substantially in the interval between deliveries, revaccination is required for optimal protection in subsequent pregnancies. The contribution of preschool-aged siblings to household transmission can be greatly reduced through the inclusion of a toddler booster on the vaccination schedule, further enhancing household-level herd protection.
Ours is the first pertussis modeling study of which we are aware to have considered the implementation of maternally targeted immunization approaches within a structured population model. Advantages of this approach include the ability to infer benefits at the level of the family unit, making model outputs readily comparable with estimates of protection obtained from case-control or cohort studies. By explicitly configuring mother-infant pairs within a household context, we were able to assess vaccine protection in the setting in which the force of infection (given introduction) was anticipated to be greatest. These targeted outcomes of immunization can reliably be observed within the household as a unit of observation, regardless of the population prevalence of infection or the level of vaccine coverage achieved. The additional flexibility to follow subsequent pregnancies allows exploration of the requirement for reimmunization within a maternal vaccination program and the contribution of siblings to infection risk.
Previous age-structured population dynamic models that have considered the impact of targeted (cocoon) and general adult immunization strategies on infant disease have produced disparate conclusions (25, 26) . While Van Rie and Hethcote (25) found that strategies including cocoon vaccination reduced infant disease more than general adolescent and adult immunization did, results were sensitive to the proportion of infants assumed to be infected through household exposure. In contrast, Coudeville (25) , our more modest estimate of cocoon effectiveness is due to the incorporation of a delay in achieving a protective cocoon following postnatal vaccination and the contribution of siblings, fathers, and community contacts to infection.
We have calibrated parameters conferring vaccine protection against effectiveness estimates from available case-control and observational studies (3, 4, (6) (7) (8) 27) , while recognizing the challenges associated with case ascertainment and confirmation of "control" status in real-world settings. The relative contribution of family members to infant infection risk appears to decline during years of high epidemic activity (28) . This observation may contribute to marked variations in the observed effectiveness of cocooning between studies, despite the demonstrated importance of mothers to infant infection risk within the household (29) . In addition, emerging data from the United States caution against systematic sources of bias in estimates of the effectiveness of maternal immunization arising from very low levels of vaccine uptake in women of lower socioeconomic status (30) , whose infants may also be at greater risk of pertussis infection (31) .
The certainty of several key assumptions in our model, as for all other models of pertussis, is necessarily constrained by an absence of robust evidence. Without a definitive correlate of vaccine protection (32) , it is difficult to confidently infer a reduction in disease risk on the basis of observed immunogenicity, necessitating our reliance on clinical endpoint studies (3, 4, (6) (7) (8) 27) . Given the recency of implementation of antenatal vaccine approaches, there is a relative paucity of data informing estimates of the persistence of protection in the newborn and the persistence of antibodies in the mother over various intervals between gestations (8) . Studies of the avidity of passively transferred antibody suggest that the timing of maternal immunization during the third trimester may be associated with differences in achievable protection (33) . Moreover, maternal immunization in late pregnancy or the perinatal period additionally stimulates production of pertussis-specific secretory immunoglobulin A (34), which may be associated with enhanced protection among breast-fed infants (34) in comparison with those receiving formula. Because the clinical implications of these latter observations are not known, we did not consider subtle differences in protection that may arise from such mechanisms.
Early studies have demonstrated blunting of vaccine responses in infants of mothers immunized during pregnancy following the primary infant vaccine series, with this blunting resolving after receipt of a booster in the second year of life (35, 36) . Given the uncertain clinical implications of this finding, we did not consider any adverse outcomes of vaccination in pregnancy on protection following completion of the primary infant course in the present model. However, should emerging evidence indicate that any reduction in vaccine protection is observed among such infants, our model can be updated to consider the implications of this finding, for both firstborn and subsequent children.
The model presented provides a structured framework within which to consider emerging evidence on targeted maternal pertussis immunization, through logical synthesis of available evidence. Our approach is sufficiently flexible to be updated with emerging evidence, further improving the robustness of model predictions, and will be adapted to consider maternal immunization approaches for alternative antigens, including influenza and emerging viral vaccines. Our approach provides useful information to aid consideration of alternative maternally targeted vaccination strategies, including the provision of inputs for cost-effectiveness models. Moreover, by defining the expectations of such programs, it can be used to guide the development of outcome measures for program evaluation.
